loxoprofen has been researched along with Bladder, Overactive in 1 studies
loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shioyama, R | 1 |
| Aoki, Y | 1 |
| Ito, H | 1 |
| Matsuta, Y | 1 |
| Nagase, K | 1 |
| Oyama, N | 1 |
| Miwa, Y | 1 |
| Akino, H | 1 |
| Imamura, Y | 1 |
| Yokoyama, O | 1 |
1 other study available for loxoprofen and Bladder, Overactive
| Article | Year |
|---|---|
Long-lasting breaches in the bladder epithelium lead to storage dysfunction with increase in bladder PGE2 levels in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cystitis, Interstitial; Dinoprostone; Disease Mode | 2008 |